Skip to main content
Premium Trial:

Request an Annual Quote

Nickels and Dimes

A publishing company is asking for a fee to retract an article, Ivan Oransky at Retraction Watch reports. "We've heard about a lot of barriers to retraction — author and editor stubbornness being the most frequent. But now there's a new one: A publisher that wants to charge authors $650 to retract," Oransky writes.

In this instance, it appears that a graduate student and his advisor both submitted the same paper to different journals for publication without the other knowing it, and both were published, Oransky says. The student Pit Pruksathorn, then at Bangkok's Chulalongkorn University, asked one journal, the American Journal of Engineering and Applied Sciences, published by Science Publications, to retract the paper.

Jeffrey Beall, a University of Colorado, Denver, a librarian and blogger at Scholarly Open Access who noticed the duplicate publication and has been included on some of the emails, writes that the fee is "unethical. Scholarly publishers have an obligation to 'maintain the integrity of the academic record' and should immediately retract an article that is to be excluded from that record, without charge to anyone. This policy of charging disincentivises paper retractions — which are sometimes necessary — by adding a fee barrier."

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.